Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates For The Next Quarter

Share:
Related ABAX
Mid-Afternoon Market Update: Dow Surges 300 Points; Quality Systems Shares Tumble
Mid-Day Market Update: Dow Jumps Over 200 Points; Amazon Shares Down On Earnings Miss
Related VIVO
UPDATE: Meridian Bioscience Announces Investment in Oasis Diagnostics; Terms Not Disclosed
Top 4 Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter.

Abaxis (NASDAQ: ABAX) is estimated to post earnings of $0.24 per share in the June quarter. Abaxis' trailing-twelve-month revenue is $178.79 million.

Meridian Bioscience (NASDAQ: VIVO) is expected to earn $0.22 per share in the June quarter. Meridian Bioscience's trailing-twelve-month operating margin is 29.72%.

SurModics (NASDAQ: SRDX) is likely to earn $0.22 per share in the June quarter. SurModics had $30.96 million in total cash for the latest quarter.

Trinity Biotech plc (NASDAQ: TRIB) may earn $0.20 per share in the March quarter. Trinity Biotech's PEG ratio is 1.88.

Posted-In: Diagnostic Substances Industry Highest EPS Estimates small-cap stocksTrading Ideas

 

Related Articles (ABAX + SRDX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters